Disclosure Panels Details Page
Multiple Myeloma/Systemic Light Chain Amyloidosis/Waldenström Macroglobulinemia Panel - Disclosures as of 11/23/2021
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Has Attended |
|---|---|---|---|---|---|
| Kehinde Adekola MD, MSCI | Blood and Marrow Transplant Clinical Trials Network - BMT CTN | None | None | None | - |
| Larry Anderson, Jr. MD, PhD | Amgen Inc. Bristol Myers Squibb GSK Janssen Pharmaceutica Products, LP Karyopharm Therapeutics |
Bristol Myers Squibb GSK Janssen Pharmaceutica Products, LP Karyopharm Therapeutics Oncopeptides |
Celgene Corporation GSK Janssen Pharmaceutica Products, LP Karyopharm Therapeutics Oncopeptides |
None | - |
| Muhamed Baljevic MD | None | None | Bristol Myers Squibb Cardinal Health CurioScience Janssen Biotech, Inc. Karyopharm Therapeutics NCCN 2020 Virtual Congress: Hematologic Malignancies Oncopeptides Inc. Sanofi-Genzyme |
None | - |
| Ryan Berardi MSc | None | None | None | None | - |
| Marian Birkeland PhD | None | None | None | None | - |
| Natalie Callander MD | None | None | None | None | - |
| Erica Campagnaro MD | None | None | None | None | - |
| Jorge Castillo MD | AbbVie, Inc. BeiGene Pharmacyclics TG Therapeutics |
BeiGene Janssen Pharmaceutica Products, LP Pharmacyclics Roche Laboratories, Inc. |
None | None | - |
| Caitlin Costello MD | Multiple Myeloma Research Foundation | Celgene Corporation Janssen Pharmaceutica Products, LP Takeda Pharmaceuticals North America, Inc. |
None | None | - |
| Eileen Cucinotta | None | None | None | None | - |
| Christopher D'Angelo MD | BeiGene Fate Therapeutics Karyopharm Therapeutics |
TG Therapeutics | None | None | - |
| Srinivas Devarakonda MD | None | None | None | None | - |
| Sarah DeVincenzo PharmD, BCPS | None | None | None | None | - |
| Noura Elsedawy MD | None | None | None | Vyriad | - |
| Colleen Erb MSN, AOCNP, CRNP | None | None | None | None | - |
| Alfred Garfall MD | Janssen Pharmaceutica Products, LP Novartis Pharmaceuticals Corporation Tmunity Therapeutics |
GSK Janssen Pharmaceutica Products, LP |
None | University of Pennsylvania, royalties on licensed IP in the field of CAR T cell therapy. | - |
| Kelly Godby MD | None | None | None | None | - |
| Kristina Gregory MSN, RN | None | None | None | None | - |
| Evelyn Handel PharmD, BCOP, BCPS | None | None | None | None | - |
| Jens Hillengass MD, PhD | None | Aptitude Health GSK Oncopeptides sanofi-aventis U.S. Skyline |
Amgen Inc. Beijing Medical Award Foundation Curio Science Patient Partners Rapid Payer Response Research to Practice |
None | - |
| Leona Holmberg MD, PhD | Bristol Myers Squibb Janssen Pharmaceutica Products, LP Merck & Co., Inc. sanofi-aventis U.S. Seattle Genetics, Inc. Takeda Pharmaceuticals North America, Inc. |
None | None | Up-To-Date | - |
| Myo Htut MD | Celgene Corporation Janssen Pharmaceutica Products, LP |
None | None | None | - |
| Carol Ann Huff MD | Glenmark / Ichnos | AstraZeneca Pharmaceuticals LP GSK Oncopeptides sanofi-aventis U.S. |
None | None | - |
| Malin Hultcrantz MD, PhD | Amgen Inc. Daiichi- Sankyo Co. GSK |
None | Bristol Myers Squibb | None | - |
| Yubin Kang MD | Apogee Biotech and RedHill Pharmaceutical Co | None | sanofi-aventis U.S. | None | - |
| Rashmi Kumar PhD | None | None | None | None | - |
| Shaji Kumar MD | AbbVie, Inc. Allogene Bristol Myers Squibb Carsgen Celgene Corporation GSK MedImmune Inc. Oncopeptides Roche Laboratories, Inc. Takeda Pharmaceuticals North America, Inc. Tenebio |
AbbVie, Inc. BeiGene Bluebird Celgene Corporation Constellation Epizyme GSK Oncopeptides Regeneron Pharmaceuticals, Inc. Roche Laboratories, Inc. sanofi-aventis U.S. Secura Takeda Pharmaceuticals North America, Inc. |
None | None | - |
| Sarah Larson MD | AbbVie, Inc. Allogene Bristol Myers Squibb Celgene Corporation Janssen Pharmaceutica Products, LP Juno Therapeutics, Inc. Pfizer Inc. sanofi-aventis U.S. |
1200 Pharma TORL Biotherapeutics |
None | None | - |
| Hans Lee MD | Amgen Inc. Celgene Corporation Janssen Pharmaceutica Products, LP National Cancer Institute Regeneron Pharmaceuticals, Inc. Takeda Pharmaceuticals North America, Inc. |
Bristol Myers Squibb Celgene Corporation Genentech, Inc. GSK Immunitis Therapeutics Janssen Pharmaceutica Products, LP Karyopharm Therapeutics Legend Biotech Oncopeptides sanofi-aventis U.S. Takeda Pharmaceuticals North America, Inc. |
None | None | - |
| Michaela Liedtke MD | Allogene Bristol Myers Squibb Caelum Celgene Corporation Janssen Pharmaceutica Products, LP Seattle Genetics, Inc. |
Alnylam Bristol Myers Squibb GSK Janssen Pharmaceutica Products, LP Karyopharm Therapeutics Kite Pharma Kura Oncology, Inc. Natera Oncopeptides sanofi-aventis U.S. Takeda Pharmaceuticals North America, Inc. |
None | None | - |
| Thomas Martin MD | Amgen Inc. Janssen Pharmaceutica Products, LP sanofi-aventis U.S. Seattle Genetics, Inc. |
GSK | None | None | - |
| John Murphy | None | None | None | None | - |
| Jim Omel MD | None | None | None | None | - |
| Donna Powell DHSc, CMD, RT(T) | None | None | None | None | - |
| Aaron Rosenberg MD | GSK | None | Takeda Pharmaceuticals North America, Inc. | None | - |
| Douglas Sborov MD, MSc | Amgen Inc. Bristol Myers Squibb GSK Janssen Pharmaceutica Products, LP |
GSK Janssen Pharmaceutica Products, LP sanofi-aventis U.S. SkylineDX |
GSK Janssen Pharmaceutica Products, LP |
None | - |
| Keith Stockerl-Goldstein MD | BioLIne Caelum Bioscineces GSK Ionis Janssen Pharmaceutica Products, LP sanofi-aventis U.S. Takeda Pharmaceuticals North America, Inc. |
None | None | Abbott Laboratories|AbbVie, Inc.|Novartis Pharmaceuticals Corporation | - |